According to FutureWise analysis the market for drug screening in 2023 was US$ 7.3 billion, and is expected to reach US$ 24.43 billion by 2031 at a CAGR of 16.30%.
Drug screening involves examining individuals for drug usage even if they don't necessarily exhibit any signs of drunkenness or a substance use disorder. It could be carried out methodically or at random in certain demographics, including those of students, athletes, and convicts. In the process of drug screening a sample of urine, blood, breath, saliva, sweat, or hair may be tested. Urine testing is the most commonly used method because it is non-invasive, quick, and capable of detecting a wide range of drugs. It can detect drugs used within 1 to 4 days, or even longer depending on the drug. Blood testing is rarely used because it is invasive and can only detect drugs a few hours after they have been used. Hair testing is less common, but it can detect some drugs if they were used within the previous 100 days.
Government agencies' strict regulations requiring alcohol and drug screening for safety reasons as well as rising efforts to track and combat substance usage are expected to boost the market growth. Also, the prevalence of substance misuse is rising globally, which has increased the necessity for screening and fuelled the demand for drug screening. Furthermore, the COVID-19 pandemic's consequences on job losses, business closures, and the economy have had a detrimental impact on people's mental health and raised rates of substance abuse. According to CDC, 13.3% of Americans started or increased substance addiction to deal with COVID-19-related anxiety or feelings, which led to a significant increase in the need for drug screening.
FutureWise Market Research has published a report that provides an insightful analysis of drug screening market trends that are affecting the overall market growth.
Request a Free Sample @ https://www.futurewiseresearch.com/healthcare-market-research/Drug-Screening-Market/5775
Drug Screening Market Segmentation:
By Product Type
- Analytical Instruments
- Immunoassay Analyzers
- Chromatography Instruments
- Breathalyzers
- Fuel Cell Breathalyzers
- Semiconductor Breathalyzers
- Other Breathalyzers
- Rapid Testing Devices
- Urine Testing Devices
- Drug Testing Cups
- DIP Cards
- Drug Testing Cassettes
- Oral Fluid Testing Devices
- Urine Testing Devices
- Consumables
- Assay Kits
- Sample Collection Devices
- Calibrators and Controls
- Other Consumables
By Drug Screening Services
- Regulated
- Non-Regulated
By Sample Type
- Urine Samples
- Breath Samples
- Oral Fluid Samples
- Hair Samples
- Other Samples
By End-user
- Workplace
- Criminal Justice Systems and Law Enforcement Agencies
- Drug Treatment Centers
- Pain Management Centers
- Schools and Colleges
- Hospitals
- Individual Users
- Drug Testing Laboratories
By Region
- North America
- Latin America
- Europe
- Asia-Pacific
- Middle East and Africa
Competitive Landscape in Drug Screening Market:
- Abbott
- Dragerwerk
- Labcorp
- Quest Diagnostics
- Alfa Scientific Designs
- Lifeloc
- MPD Inc.
- Orasure
- Omega Laboratories
- Premier Biotech
- Psychemedics
- Roche
- Shimadzu
- Siemens Healthineers
- Thermo Fisher Scientific
Ask For Discount: https://www.futurewiseresearch.com/contact.aspx?rpt=5775%20type=discount
**Objectives of this Study: **
- To provide a comprehensive analysis of the Drug Screening Market By Product Type, By Drug Screening Services, By Sample Type, By End User and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are free of charge with the purchase of any license of the report.
- You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com
FutureWise Research
Contact Person: Vinay Thaploo.
Email: sales@futurewiseresearch.com
Contact Number: Asia: +91 8605575209 | USA: +1 3477094931
Website: www.futurewiseresearch.com
